Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

341. Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients

Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

342. Self-management of oral anticoagulant therapy: a systematic review and meta-analysis

Self-management of oral anticoagulant therapy: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

343. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

344. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials

Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

345. Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness

Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness Brown A, Wells P, Jaffey J, McGahan L, Poon M-C, Cimon K, Campbell K Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brown A, Wells P, Jaffey J, McGahan L, Poon M-C, Cimon K, Campbell K. Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Technology Report No 72. 2007 Authors' objectives The objectives were to assess the clinical and economic implications of point-of-care (POC) monitoring

2007 Health Technology Assessment (HTA) Database.

346. Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert)

Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert) Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert) Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert) Swedish Council on Technology Assessment in Health Care Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Swedish Council on Technology Assessment in Health Care. Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert) Stockholm: The Swedish Council on Health Technology Assessment (SBU). SBU Alert report no 2007-05. 2007 Authors' objectives Primary questions: What are the benefits of self-testing and self-management compared to using conventional management (testing and dosing at healthcare facilities) for patients needing long-term

2007 Health Technology Assessment (HTA) Database.

347. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling

Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling Connock M (...) , Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, Song F Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, Song F. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic

2007 Health Technology Assessment (HTA) Database.

348. An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation

An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation Leigh J P, White R H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the clinical and economic impact of warfarin versus a second anticoagulant in hypothetical cohort of 70-year-old patients with atrial fibrillation. There was substantial variation in rates and costs of adverse events when considering all possible scenarios, but the difference in costs between the two drugs was modest. Overall, the analysis

2007 NHS Economic Evaluation Database.

349. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study

Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study Nurmohamed S A, Vervloet M G, Girbes A R, Ter Wee P M, Groeneveld A B Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study compared the costs and effects of continuous venovenous haemofiltration (CVVH) alone with CVVH plus predilution regional citrate anticoagulation (RCA) for critically-ill patients. The authors concluded that both treatments had similar costs

2007 NHS Economic Evaluation Database.

350. Patient self management of anticoagulants resulted in fewer major complications than clinic-based management Full Text available with Trip Pro

Patient self management of anticoagulants resulted in fewer major complications than clinic-based management Patient self management of anticoagulants resulted in fewer major complications than clinic-based management | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Patient self management of anticoagulants resulted in fewer major complications than clinic-based management Article Text Treatment Patient self management of anticoagulants

2006 Evidence-Based Nursing

351. Anticoagulant plus antiplatelet treatment increased the risk of bleeding in atrial fibrillation Full Text available with Trip Pro

Anticoagulant plus antiplatelet treatment increased the risk of bleeding in atrial fibrillation Anticoagulant plus antiplatelet treatment increased the risk of bleeding in atrial fibrillation | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Anticoagulant plus antiplatelet treatment increased the risk of bleeding in atrial fibrillation Article Text Aetiology Anticoagulant plus antiplatelet treatment increased the risk of bleeding in atrial

2006 Evidence-Based Medicine

352. Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. (Abstract)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. Venous thromboembolism (VTE) is the term given to any thromboembolic event (blocking of a blood vessel by a blood clot) occurring in the venous system. The current treatment recommended for VTE is anticoagulation (reduction of the blood's ability to clot). The aim of this review is to summarize results from randomized controlled trials (RCTs) for the effectiveness of anticoagulants (...) (heparins, including low molecular weight heparins and vitamin K antagonists) in the treatment of VTE, compared to non-steroidal anti-inflammatory drugs (NSAIDs) or placebo.To examine the randomized controlled evidence for the effectiveness and safety of anticoagulant treatment compared to NSAIDs or placebo in patients with VTE on the incidence of fatal and non-fatal pulmonary emboli (PE) and the recurrence or extension of deep vein thrombosis (DVT).The Cochrane Peripheral Vascular Diseases (PVD) Group

2006 Cochrane

353. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Full Text available with Trip Pro

Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction Patatanian E, Fugate SE CRD summary This 2006 review concluded that dental extractions in anticoagulated patients could be performed with haemostatic mouthwashes to control local bleeding, without temporary discontinuation of oral anticoagulants. The limitations (...) of the review methods, and a lack of data on thromboembolism risk, mean that these conclusions may be overstated. Authors' objectives To evaluate the efficacy and safety of local-acting haemostatic agents to prevent bleeding in patients taking oral anticoagulants and undergoing dental extraction. Searching MEDLINE, IPA and EMBASE were searched in July 2006 for English-language publications. Search terms were reported. Bibliographies of relevant papers were manually searched. Study selection Eligible

2006 DARE.

354. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. (Abstract)

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Oral anticoagulation therapy reduces risk of vascular events in patients with atrial fibrillation. However, long-term monitoring is necessary and many patients cannot achieve optimum anticoagulation. We assessed whether clopidogrel plus aspirin was non-inferior to oral (...) anticoagulation therapy for prevention of vascular events.Patients were enrolled if they had atrial fibrillation plus one or more risk factor for stroke, and were randomly allocated to receive oral anticoagulation therapy (target international normalised ratio of 2.0-3.0; n=3371) or clopidogrel (75 mg per day) plus aspirin (75-100 mg per day recommended; n=3335). Outcome events were adjudicated by a blinded committee. Primary outcome was first occurrence of stroke, non-CNS systemic embolus, myocardial

2006 Lancet Controlled trial quality: predicted high

355. D-dimer testing to determine the duration of anticoagulation therapy. (Abstract)

D-dimer testing to determine the duration of anticoagulation therapy. The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation.We performed D-dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist (...) for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years.The D-dimer assay was abnormal in 223 of 608 patients (36.7%). A total of 18 events occurred among the 120 patients who stopped anticoagulation (15.0%), as compared with 3

2006 NEJM Controlled trial quality: predicted high

356. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

357. Self-monitoring and self-management of oral anticoagulant therapy

Self-monitoring and self-management of oral anticoagulant therapy Self-monitoring and self-management of oral anticoagulant therapy Self-monitoring and self-management of oral anticoagulant therapy HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Self-monitoring and self-management of oral anticoagulant therapy. Lansdale: HAYES, Inc (...) .. Directory Publication. 2006 Authors' objectives Patients receiving long-term oral anticoagulation therapy (OAT) can monitor their own coagulation control with portable devices that measure capillary whole-blood prothrombin time (PT). The anticoagulant activity of warfarin is monitored by the prothrombin time (PT) using the International Normalized Ratio (INR). After testing, patients either notify their physicians of the results or use an individualized algorithm to adjust their warfarin dosage

2006 Health Technology Assessment (HTA) Database.

358. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy Full Text available with Trip Pro

Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy Regier D A, Sunderji R, Lynd L D, Gin K, Marra C A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The authors compared oral anticoagulation therapy through self-management with oral anticoagulation therapy through physician management for patients with atrial fibrillation or with a mechanical heart valve. Type of intervention Primary and secondary prevention. Economic study type Cost-utility analysis. Study population The study population comprised

2006 NHS Economic Evaluation Database.

359. Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model

Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.

360. Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis

Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.